Details for New Drug Application (NDA): 206791
✉ Email this page to a colleague
The generic ingredient in CISATRACURIUM BESYLATE PRESERVATIVE FREE is cisatracurium besylate. There are nine drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the cisatracurium besylate profile page.
Summary for 206791
Tradename: | CISATRACURIUM BESYLATE PRESERVATIVE FREE |
Applicant: | Somerset Theraps Llc |
Ingredient: | cisatracurium besylate |
Patents: | 0 |
Pharmacology for NDA: 206791
Physiological Effect | Neuromuscular Nondepolarizing Blockade |
Suppliers and Packaging for NDA: 206791
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CISATRACURIUM BESYLATE PRESERVATIVE FREE | cisatracurium besylate | INJECTABLE;INJECTION | 206791 | ANDA | Somerset Therapeutics, LLC | 70069-141 | 70069-141-01 | 1 VIAL in 1 CARTON (70069-141-01) / 5 mL in 1 VIAL |
CISATRACURIUM BESYLATE PRESERVATIVE FREE | cisatracurium besylate | INJECTABLE;INJECTION | 206791 | ANDA | Somerset Therapeutics, LLC | 70069-141 | 70069-141-10 | 10 VIAL in 1 CARTON (70069-141-10) / 5 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2MG BASE/ML | ||||
Approval Date: | Feb 20, 2019 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 10MG BASE/ML | ||||
Approval Date: | Feb 20, 2019 | TE: | AP | RLD: | No |
Complete Access Available with Subscription